Blockage of 2-Deoxy-<scp>d</scp>-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy - Concepedia

Concepedia

Publication | Closed Access

Blockage of 2-Deoxy-<scp>d</scp>-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy

66

Citations

31

References

2004

Year

Hendrik Seeliger, Markus Guba, Gudrun E. Koehl, Axel Doenecke, Markus Steinbauer, Christiane J. Bruns, Christine Wagner, Erika Frank, Karl‐Walter Jauch, Edward K. Geissler

Clinical Cancer Research

Abstract

Inhibition of dRib-induced angiogenesis with rapamycin counteracts a potential TP-based escape mechanism for colorectal cancer under 5-FU therapy, introducing a novel, clinically feasible, combination treatment option for this common neoplasm.

References

	Year	Citations

Page 1